Metraipolis › archive › dc_728ff4c85ea5

Galantamine-Escitalopram Combination Therapy in Alzheimer's Comorbid Depression Model in Mice: Role of BDNF/KYN Pathways, Neuroinflammation, and Oxidative… — Europe PMC PMID:41696300

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41696300
DOI
10.1021/acsomega.5c08276
License (as archived)
solo-consultazione
Archived
2026-11-06T11:39:43.004Z
SHA-256 of the archived text
6d32089391dd35a0366194860c6f1b2e966cbf5654929d593d38ef5f2d754e61
Stable URL of this page
https://metraipolis.com/documento/dc_728ff4c85ea5

How to cite

Galantamine-Escitalopram Combination Therapy in Alzheimer's Comorbid Depression Model in Mice: Role of BDNF/KYN Pathways, Neuroinflammation, and Oxidative… — Europe PMC PMID:41696300 — Europe PMC (en), https://europepmc.org/article/MED/41696300 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_728ff4c85ea5 (Metraipolis archive dc_728ff4c85ea5, sha256 6d32089391dd35a0366194860c6f1b2e966cbf5654929d593d38ef5f2d754e61)
BibTeX
@misc{dc728ff4c85ea5,
  title = {Galantamine-Escitalopram Combination Therapy in Alzheimer's Comorbid Depression Model in Mice: Role of BDNF/KYN Pathways, Neuroinflammation, and Oxidative… — Europe PMC PMID:41696300},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41696300},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_728ff4c85ea5; sha256 6d32089391dd35a0366194860c6f1b2e966cbf5654929d593d38ef5f2d754e61},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41696300. Agents can read the archived copy with the MCP tool read_document.